Bionano Genomics, Inc. Sustainability Profile
Bionano Genomics, Inc., a leading player in the genomics industry, is headquartered in the United States, with significant operations across North America and Europe. Founded in 2003, the company has made remarkable strides in genomic analysis, particularly through its innovative optical genome mapping technology. This unique approach allows researchers to visualise and analyse complex genomic structures with unprecedented clarity. Bionano's flagship product, the Saphyr system, stands out for its ability to detect structural variations in DNA that traditional sequencing methods often miss. This capability positions Bionano as a vital resource for researchers in oncology, genetic disorders, and other fields requiring detailed genomic insights. With a strong market presence and a commitment to advancing genomic research, Bionano Genomics continues to drive innovation and enhance the understanding of genetic diseases.
DitchCarbon Score
How does Bionano Genomics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Bionano Genomics, Inc.'s score of 23 is lower than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Bionano Genomics, Inc.'s reported carbon emissions
Bionano Genomics, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Bionano Genomics may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives at this time. As the company operates within the genomics sector, it may face increasing pressure to adopt sustainable practices and transparency in emissions reporting in line with broader industry trends.
How Carbon Intensive is Bionano Genomics, Inc.'s Industry?
How Carbon Intensive is Bionano Genomics, Inc.'s Location?
Bionano Genomics, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Bionano Genomics, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
